Navigating lab informatics solutions to support new therapeutics
With the maturation of new therapeutic modalities like ADCs, chemically modified oligos, and mRNA vaccines, collaboration between molecular biology and chemistry teams has reached unprecedented levels. Historically, these teams operated in a separate ELN and registration system, but today’s new therapeutic modalities and multimodal discovery workflows often require unified data and workflows.
